ATEC icon

Alphatec Holdings

15.03 USD
-0.02
0.13%
At close Updated Sep 16, 4:00 PM EDT
Pre-market
After hours
15.09
+0.06
0.4%
1 day
-0.13%
5 days
-4.57%
1 month
-5.23%
3 months
36.39%
6 months
54.15%
Year to date
65.89%
1 year
154.31%
5 years
146.39%
10 years
156.05%
 

About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Employees: 867

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

627% more call options, than puts

Call options by funds: $85.6M | Put options by funds: $11.8M

62% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 65

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

3% more funds holding

Funds holding: 230 [Q1] → 236 (+6) [Q2]

11.87% less ownership

Funds ownership: 80.9% [Q1] → 69.03% (-11.87%) [Q2]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]

58% less capital invested

Capital invested by funds: $2.64B [Q1] → $1.12B (-$1.52B) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$18
20% upside
Avg. target
$20
33% upside
High target
$22
46% upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Barclays
Matt Miksic
$22
Overweight
Maintained
4 Aug 2025
Canaccord Genuity
Caitlin Cronin
$20
Buy
Maintained
1 Aug 2025
Lake Street
Ben Haynor
$18
Buy
Assumed
16 Jun 2025

Financial journalist opinion

Neutral
Business Wire
1 month ago
ATEC to Participate in Upcoming Conferences
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025. The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET. The Piper Sandler MedTech and Di.
ATEC to Participate in Upcoming Conferences
Negative
Finbold
1 month ago
These 3 health tech stocks spiked 37% in a day; Time to buy?
While the broader stock market suffered steep losses on Friday amid trade policy shifts and troubling economic data, select health technology equities stood out.
These 3 health tech stocks spiked 37% in a day; Time to buy?
Positive
The Motley Fool
1 month ago
Alphatec (ATEC) Q2 Revenue Jumps 27%
Alphatec (ATEC 30.44%), a medical technology company specializing in spinal surgery solutions, reported earnings on July 31, 2025. The release showed top- and bottom-line figures (GAAP revenue and non-GAAP EPS) that easily topped analyst estimates.
Alphatec (ATEC) Q2 Revenue Jumps 27%
Neutral
Seeking Alpha
1 month ago
Alphatec Holdings, Inc. (ATEC) Q2 2025 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants J. Todd Koning - Executive VP & CFO Patrick S.
Alphatec Holdings, Inc. (ATEC) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Alphatec (ATEC) Beats Q2 Earnings and Revenue Estimates
Alphatec (ATEC) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to a loss of $0.29 per share a year ago.
Alphatec (ATEC) Beats Q2 Earnings and Revenue Estimates
Neutral
Business Wire
1 month ago
ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2025, and recent corporate highlights. Second Quarter 2025 Financial Results   Quarter Ended June 30, 2025 Total revenue $186 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $142 million Non-GAAP operating expenses $12.
ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance
Neutral
Business Wire
2 months ago
ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the l.
ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025
Neutral
Seeking Alpha
4 months ago
Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Matt Miksic - Barclays Mathew Blackman - Stifel Young Li - Jefferies Eric Anderson - TD Cowen David Saxon - Needham Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's First Quarter Financial Results.
Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
4 months ago
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.34 per share a year ago.
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates
Neutral
Business Wire
4 months ago
ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results   Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA.
ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance
Charts implemented using Lightweight Charts™